A 47-year-old nonsmoker, HIV-negative patient presented with dry cough, breathlessness, hoarseness of voice and low-grade fever of 6 months duration. His chest X-ray was normal. CT scan of the chest \[[Figure 1](#F1){ref-type="fig"}\] revealed irregularity of the anterior tracheal mucosa. Bronchoscopy was done and this showed \[[Figure 2](#F2){ref-type="fig"}\] ulcerated vocal cords and pseudomembrane formation of the lining mucosa of the trachea and bronchi.

![CT chest showing irregularity and abnormality of anterior wall of trachea](LI-28-226-g001){#F1}

![Initial bronchoscopic picture, lower end of trachea](LI-28-226-g002){#F2}

Q1. What was the disease causing these bronchoscopic changes?

ANSWER {#sec1-1}
======

Endobronchial tuberculosis with pseudomembrane formation

BAL revealed presence of many AFB. Endobronchial Biopsy showed granulomatous inflammation consistent with tuberculosis \[[Figure 3](#F3){ref-type="fig"}\]. The presentation of endobronchial tuberculosis with pseudomembrane formation of the mucosa of trachea and bronchi is unusual.\[[@ref1][@ref2]\]

![Endobronchial biopsy showing granulomatous inflammation consistent with tuberculosis, eosin and hematoxolin staining, scanner 4×, ocular 10×, 40 magnification](LI-28-226-g003){#F3}

Patient was started on anti-tuberculous therapy with 2 months of Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide followed by 7 months of Isoniazid, Rifampicin and Ethambutol and the treatment given was non-DOTS. Patient was given daily regimen, as per body weight, individual Antituberculous drugs were given, and it was a nonsupervised therapy. A short duration, 4 weeks, of oral steroids was also initiated. At the end of 9 months of antituberculosis therapy, patient\'s repeat bronchoscopy \[[Figure 4](#F4){ref-type="fig"}\] revealed residual tracheal stenosis at lower one third of trachea, which was managed conservatively.

![Stenosis at lower end of trachea, at the end of antituberculous treatment](LI-28-226-g004){#F4}

**Source of Support:** Nil

**Conflict of Interest:** None declared.
